Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model
/in Dendritic Cells, International Publications, Prostate CancerPolarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors
/in Dendritic Cells, International PublicationsAntigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells
/in Dendritic Cells, International PublicationsAdjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenDendritic cell vaccines to combat glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines
/in Hepatocellular Carcinoma, International PublicationsDifferential effects of Paclitaxel on dendritic cell function
/in Dendritic Cells, International PublicationsAlpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells
/in Dendritic Cells, International PublicationsCombined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma
/in Cervical Cancer, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer